University Hospital Ulm

Futó vizsgálatok

• Még nem toboroz

  A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination with Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants with First-Line Metastatic Pancreatic Ductal Adenocarcinoma

  2025-522563-15-00· 2/3. fázis· AbbVie Deutschland GmbH & Co. KG· Forrás

• Még nem toboroz

  Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma

  NCT07291102· 3. fázis· Nationwide Children's Hospital· Forrás

• Még nem toboroz

  Post-intervention dual antiplatelet therapy for mild stroke

  2026-525681-22-00· 3. fázis· Technische Universitaet Dresden· Forrás

• Még nem toboroz

  A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma

  NCT07728188· 3. fázis· AbbVie· Forrás

• Toboroz

  SIL204-SL Treatment for Locally Advanced Pancreatic Cancer

  2025-525157-39-00· 2/3. fázis· Silexion Therapeutics Ltd.· Forrás

• Még nem toboroz

  An Open-label, DDI Study to Investigate the Effects of Duvakitug on the PK of Selected Cytochrome P450 Substrates

  NCT07923383· 1. fázis· Sanofi· Forrás

• Toboroz

  Cevostamab in Combination With Pomalidomide and Dexamethasone After BCMA- Targeting CAR T-Cell Therapy in Participants With Previously Treated Multiple Myeloma

  NCT07825064· 2. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  Efficacy of Asciminib in Chronic Phase CML Patients With T315I Mutations

  NCT07789574· 2. fázis· Thomas Ernst, Prof. Dr. med.· Forrás

• Még nem toboroz

  Evaluating the Effects of the EXOPULSE Suit on Mobility, Walking Ability, and Balance in People With Multiple Sclerosis

  NCT07897760· Otto Bock Healthcare Products GmbH· Forrás

• Toboroz

  A clinical trial to assess the efficacy and safety of ontunisertib compared to placebo in patients with fibrostenosing Crohn’s disease

  2026-525197-19-00· 2. fázis· Agomab Spain S.L.U.· Forrás

• Toboroz

  Phase 3 Study of Investigator Choice of Chemotherapy with or without Zoldonrasib as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma

  2025-524928-21-00· 3. fázis· Revolution Medicines Inc.· Forrás

• Még nem toboroz

  Phase 3 Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC 6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma

  2025-524969-24-00· 3. fázis· Revolution Medicines Inc.· Forrás

• Toboroz

  A Phase III, Open-Label, Randomised, Multicentre, Global Study of Adjuvant Datopotamab Deruxtecan in Combination With Rilvegostomig in Participants With High-risk Muscle Invasive Urothelial Carcinoma.

  2025-525030-57-00· 3. fázis· AstraZeneca AB· Forrás

• Még nem toboroz

  Continuous or Intermittent Cetuximab Plus FOLFIRI as First-line Treatment in RAS/BRAF Wild-type mCRC Patients

  NCT07004413· 3. fázis· Charite University, Berlin, Germany· Forrás

• Toboroz

  A clinical trial to learn about the effects of IEV407 when given alone or with endocrine therapy in people with advanced breast cancer

  2025-522707-26-00· 1. fázis· Novartis Pharma AG· Forrás

• Még nem toboroz

  A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies

  NCT07719348· 1/2. fázis· Servier· Forrás

• Toboroz

  Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)

  NCT07711002· 3. fázis· AstraZeneca· Forrás

• Toboroz

  A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)

  2025-525009-18-00· 3. fázis· Incyte Corp.· Forrás

• Még nem toboroz

  AIEOP-BFM ALL 2025 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia

  2025-522190-11-01· 3. fázis· Universitaetsklinikum Schleswig-Holstein AöR· Forrás

• Toboroz

  A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  NCT07753993· 3. fázis· AstraZeneca· Forrás

• Toboroz

  A study to evaluate the efficacy of oxaliplatin- or gemcitabine-based chemotherapy after allocation by standard criteria or by genetic markers in patients with resected pancreatic carcinoma

  NCT05314998· 3. fázis· Universitaetsklinikum Heidelberg AöR· Forrás

• Toboroz

  A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer

  NCT07673887· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Toboroz

  A Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

  2026-525234-39-00· 1. fázis· Janssen Cilag International· Forrás

• Toboroz

  Registry for Duchenne and Becker Muscular Dystrophy

  NCT07402122· Dr. Andreas Ziegler· Forrás

• Toboroz

  Pridopidine Phase 3 Study in Huntington's Disease

  NCT07609108· 3. fázis· Prilenia· Forrás

• Toboroz

  A Randomized Phase 1 / 2 Trial Aiming to Restore UNC13A Function in People living with ALS: FUNCtion ALS

  2025-523111-11-00· 1/2. fázis· Trace Neuroscience Inc.· Forrás

• Még nem toboroz

  GMMG-HD11/DSMM XXI/64007957MMY3010

  NCT07671287· 3. fázis· University of Heidelberg Medical Center· Forrás

• Meghívásos bevonás

  Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD

  NCT07652294· 2. fázis· Spyre Therapeutics, Inc.· Forrás

• Toboroz

  A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with FOLFOX versus Bevacizumab in Combination with FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer (HARMONi-GI3)

  2025-521587-35-00· 3. fázis· Summit Therapeutics Inc.· Forrás

• Toboroz

  ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer

  NCT06801899· Insel Gruppe AG, University Hospital Bern· Forrás

• Toboroz

  PREFer

  NCT06916416· 2. fázis· University Of Cologne· Forrás

• Toboroz

  A Phase 2 Platform Study to Evaluate Therapies for Inflammatory Bowel Disease

  2025-522001-38-00· 2. fázis· Mirador Therapeutics Inc.· Forrás

• Még nem toboroz

  Phase 2 trial of ARPI to AR-degrader (BMS-986365) switch for suboptimal PSA-response in mCSPC (eARly-SWITCH).

  2025-523672-23-00· 2. fázis· UroTrials GmbH· Forrás

• Toboroz

  A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT07577856· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

  NCT07577843· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis

  NCT07571174· 1. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic Lateral Sclerosis (ALS)

  NCT07571200· 1. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS (PREVAiLS)

  2025-524002-16-00· 3. fázis· Ferrer Internacional S.A.· Forrás

• Toboroz

  Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

  NCT07566156· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Toboroz

  Safety and Clinical Applicability of Transcorneal Electrical Stimulation (TES) in Geographic Atrophy

  NCT07531927· Okuvision GmbH· Forrás

• Toboroz

  A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

  NCT07483073· 2. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

  NCT07483099· 2. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)

  NCT07221669· 3. fázis· Biogen· Forrás

• Toboroz

  A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

  NCT07419295· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

  NCT07365995· 3. fázis· BioNTech SE· Forrás

• Toboroz

  A Prospective Observational Trial to Assess Treatment Sequences and Factors That Impact Overall Sur-vival in Patients With Chronic Lymphocytic Leukaemia (CLL) Treated Within First-line Studies of the GCLLSG

  NCT06792994· German CLL Study Group· Forrás

• Toboroz

  Improved Management of Patients With Recent-Onset Stable Chest Pain

  NCT07476040· Philipps University Marburg· Forrás

• Toboroz

  LY4268989 (MORF-057) Co-Administered with Mirikizumab in Adults with Moderately to Severely Active Ulcerative Colitis: A Phase 2 Study

  2025-522338-30-00· 2. fázis· Eli Lilly & Co.· Forrás

• Toboroz

  Cerebral Small Vessel Disease Progression Dependent on Stroke Type

  NCT07611136· Johannes Dorst· Forrás

• Toboroz

  A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

  NCT07463183· 2. fázis· Merck Sharp & Dohme LLC· Forrás

Showing 50 of 400.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok27 toboroz
• Vastagbélrák18 toboroz
• Hasnyálmirigyrák17 toboroz
• Akut mieloid leukémia (AML)16 toboroz
• Krónikus limfoid leukémia (CLL)16 toboroz
• Crohn-betegség15 toboroz
• Colitis ulcerosa13 toboroz
• Akut limfoid leukémia (ALL)12 toboroz
• Áttétes emlőrák12 toboroz
• Máj- és epeúti rák11 toboroz
• Gyomor- és nyelőcsőrák9 toboroz
• Prosztatarák9 toboroz
• Amiotrófiás laterálszklerózis (ALS)8 toboroz
• Mielodiszplasztikus szindróma (MDS)8 toboroz
• Mielóma multiplex8 toboroz
• Hólyagrák7 toboroz
• Időskori makuladegeneráció7 toboroz
• Petefészekrák7 toboroz
• Krónikus mieloid leukémia (CML)6 toboroz
• Méhtestrák6 toboroz
• Sclerosis multiplex (SM)6 toboroz
• Tüdőrák6 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)5 toboroz
• Follikuláris limfóma5 toboroz
• Huntington-kór5 toboroz
• Alzheimer-kór4 toboroz
• Köpenysejtes limfóma4 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)4 toboroz
• Mieloproliferatív neopláziák4 toboroz
• Stroke (szélütés)4 toboroz
• Aortic stenosis3 toboroz
• Epilepszia3 toboroz
• Fej-nyaki daganatok3 toboroz
• Hodgkin-limfóma3 toboroz
• Magas vérnyomás3 toboroz
• Parkinson-kór3 toboroz
• Koszorúér-betegség2 toboroz
• Krónikus vesebetegség2 toboroz
• Melanóma2 toboroz
• Pitvarfibrilláció2 toboroz
• Szarkóma2 toboroz
• Tripla negatív emlőrák2 toboroz
• Vesedaganat2 toboroz
• 1-es típusú cukorbetegség1 toboroz
• 2-es típusú cukorbetegség1 toboroz
• Aortic aneurysm1 toboroz
• Coeliac disease1 toboroz
• Dermatomyositis and polymyositis (myositis)1 toboroz
• Duchenne-izomdisztrófia1 toboroz
• Elhízás1 toboroz
• Graves' disease and hyperthyroidism1 toboroz
• HIV-fertőzés1 toboroz
• Multiple system atrophy1 toboroz
• Myasthenia gravis1 toboroz
• Myocarditis1 toboroz
• Neuroblasztóma1 toboroz
• Pajzsmirigyrák1 toboroz
• Pompe-betegség1 toboroz
• Spinális izomatrófia (SMA)1 toboroz
• Szívelégtelenség1 toboroz
• Thalassaemia1 toboroz
• Vascular dementia1 toboroz

Lezárt vizsgálatok

• Lezárult

  A clinical trial to learn about the effects of VHB937 in people with Alzheimer's disease

  2024-516966-12-00· 2. fázis· Novartis Pharma AG· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease

  NCT07246941· 1. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A 52-week, Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of Siplizumab in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients (AURORA)

  NCT06453668· 1. fázis· Itb-Med AB· Forrás

• Fut, nem toboroz

  A Study to Investigate the Efficacy and Safety of Brivekimig in Adult Participants With Ulcerative Colitis

  NCT06975722· 2. fázis· Sanofi· Forrás

• Lezárult

  A study to investigate efficacy and safety of SAR441566 in patients with ulcerative colitis

  NCT06867094· 2. fázis· Sanofi-Aventis Recherche & Developpement· Forrás

• Lezárult

  A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of BG-60366 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer

  NCT06685718· 1. fázis· BeOne Medicines AG· Forrás

• Lezárult

  A Study of Eciskafusp Alfa and Bacillus Calmette-Guérin (BCG) in Participants with High-Risk Bladder Cancer Unresponsive to BCG Treatment

  2024-515410-41-00· 1/2. fázis· F. Hoffmann-La Roche AG· Forrás

• Toboroz

  Efficacy and Safety Study of Once-Daily Extended-Release Levetiracetam in Drug-resistant Focal Onset Seizures

  2024-514499-42-00· 3. fázis· Neuraxpharm Pharmaceuticals S.L.· Forrás

• Lezárult

  A study to evaluate S227928 as a Single Agent and in Combination with Venetoclax in Patients with R/R AML, MDS/AML, or CMML

  NCT06563804· 1/2. fázis· Institut De Recherches Internationales Servier IRIS· Forrás

• Fut, nem toboroz

  A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

  NCT06291220· 1. fázis· AbbVie· Forrás

• Lezárult

  Efficacy, Safety and Tolerability of BHV-7000 in Subjects with Idiopathic Generalized Epilepsy with Generalized Tonic-clonic Seizures – SHINE

  NCT06425159· 2/3. fázis· Biohaven Therapeutics Ltd.· Forrás

• Fut, nem toboroz

  A Study Assessing Adverse Events and Disease Activity of Intravenously (IV) Infused Telisotuzumab Adizutecan in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer

  NCT06614192· 2. fázis· AbbVie· Forrás

• Lezárult

  Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers

  NCT06667414· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  Phase IIa Study Evaluating AZD7798 in Crohn's Disease

  NCT06450197· 2. fázis· AstraZeneca· Forrás

• Lezárult

  Efficacy and Safety of Rosnilimab in Subjects with Ulcerative Colitis

  2023-508679-34-00· 2. fázis· Anaptysbio Inc.· Forrás

• Toboroz

  Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

  NCT06252649· 3. fázis· Amgen· Forrás

• Lezárult

  Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis

  NCT06430671· 1. fázis· Cellerys AG· Forrás

• Lezárult

  A study to investigate the efficacy and safety of luveltamab tazevibulin versus IC chemotherapy in women with ovarian cancer (including fallopian tube or primary peritoneal cancers) expressing FOLR1

  NCT05870748· 2. fázis· Sutro Biopharma Inc.· Forrás

• Lezárult

  A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants with Moderate to Severe Ulcerative Colitis

  2023-506655-19-00· 2. fázis· Genentech Inc.· Forrás

• Fut, nem toboroz

  Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma

  NCT06216158· 3. fázis· University of Heidelberg Medical Center· Forrás

• Fut, nem toboroz

  A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis

  NCT06257875· 2. fázis· AbbVie· Forrás

• Lezárult

  The PROTEMBO Trial

  NCT05873816· Protembis GmbH· Forrás

• Lezárult

  A Study of Tobemstomig/RO7247669 Combined with Nab-Paclitaxel Compared with Pembrolizumab Combined with Nab-Paclitaxel in Participants with Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer

  2022-502457-34-00· 2. fázis· F. Hoffmann-La Roche AG· Forrás

• Lezárult

  A Trial to Investigate TransCon TLR7/8 Agonist in Combination with Pembrolizumab, TransCon TLR7/8 Agonist in Combination with TransCon IL-2 β/γ, or Pembrolizumab Monotherapy as Neoadjuvant Therapy in Participants with Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)

  2023-506092-10-00· 2. fázis· Ascendis Pharma Oncology Division A/S· Forrás

• Lezárult

  Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)

  NCT06182085· 2. fázis· PRInnovation GmbH· Forrás

• Visszavonták

  Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHN

  NCT05743270· 2. fázis· Replimune, Inc.· Forrás

• Fut, nem toboroz

  A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

  NCT06105632· 2. fázis· Pfizer· Forrás

• Leállították

  Continuation Study for Latozinemab

  NCT06111014· 3. fázis· Alector Inc.· Forrás

• Leállították

  IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart Attack

  NCT06139328· 2. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  Randomised, double-blind, placebo-controlled study to assess safety and efficacy of PRI-002 in patients with MCI or mild dementia due to Alzheimer’s disease (AD)

  2022-503148-41-00· 2. fázis· Prinnovation GmbH· Forrás

• Lezárult

  A clinical trial to assess the safety and effects of AGMB-129 compared to placebo in patients with fibrostenotic Crohn’s disease.

  2022-502789-26-01· 2. fázis· Agomab Spain S.L.U.· Forrás

• Fut, nem toboroz

  A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation

  NCT06045806· 3. fázis· Celgene· Forrás

• Lezárult

  EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma

  NCT06390059· 2. fázis· NovoCure Ltd.· Forrás

• Lezárult

  STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease

  NCT05843578· 2. fázis· Agomab Spain S.L.U.· Forrás

• Fut, nem toboroz

  Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease

  NCT05910528· 2. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Long-term Safety and Efficacy of Efavaleukin Alfa in Subjects With Moderately to Severely Active Ulcerative Colitis

  NCT05672199· 2. fázis· Amgen Inc.· Forrás

• Lezárult

  Safety and Efficacy of the Olympus CADe System in Real-time Colonoscopy

  NCT05943288· Olympus Europe SE & Co. KG· Forrás

• Lezárult

  A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma

  NCT05805501· 2. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma

  NCT05804032· 3. fázis· University of Heidelberg Medical Center· Forrás

• Lezárult

  A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Patients with Previously Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma

  2023-505816-39-00· 2. fázis· F. Hoffmann-La Roche AG· Forrás

• Lezárult

  Allogeneic stem cell transplantation vs. conventional therapy as salvage therapy for relapsed / progressed patients with multiple myeloma after first-line therapy (AlloRelapseMMStudy)

  NCT05675319· 3. fázis· University Medical Center Hamburg-Eppendorf· Forrás

• Fut, nem toboroz

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Assess the Efficacy, Safety, Tolerability, PK, and Biomarker Effects of PTC857 in Adult Subjects With Amyotrophic Lateral Sclerosis (CARDINALS)

  NCT05349721· 2. fázis· PTC Therapeutics Inc.· Forrás

• Fut, nem toboroz

  GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease

  NCT05686551· 2. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

  NCT05686070· 3. fázis· Bayer· Forrás

• Lezárult

  ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2

  NCT05507216· 3. fázis· Abivax S.A.· Forrás

• Lezárult

  Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder

  NCT05512377· 2. fázis· Boehringer Ingelheim· Forrás

• Fut, nem toboroz

  Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis

  NCT05588843· 2. fázis· Sanofi· Forrás

• Lezárult

  A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC

  NCT05611671· 2. fázis· Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)· Forrás

• Lezárult

  A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures

  NCT05614063· 3. fázis· Xenon Pharmaceuticals Inc.· Forrás

Showing 50 of 169.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Akut mieloid leukémia (AML)33 munka · 31 vizsgálat
• Hólyagrák29 munka · 13 vizsgálat
• Huntington-kór26 munka · 11 vizsgálat
• Amiotrófiás laterálszklerózis (ALS)18 munka · 17 vizsgálat
• Fej-nyaki daganatok12 munka · 16 vizsgálat
• Krónikus limfoid leukémia (CLL)8 munka · 27 vizsgálat
• Frontotemporális demencia7 munka · 2 vizsgálat
• Aplastic anaemia4 munka · 1 vizsgálat